Quarterly Activities Report
Quarterly Activities Report
Perth, Jan 31, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to provide its quarterly activities report for the period ended 31 December 2017.

Quarterly Overview:

MMJ Investment Portfolio

- MMJ initiates strategy to expand market position through further strategic investments within the global cannabis sector

- Strategic investments in eSense-Lab (ASX:ESE) and Canadian private businesses Weed Me and Dosecann solidifies MMJ's position in the rapidly evolving global cannabis sector

Harvest One Cannabis Inc. (MMJ holding 53,333,333 shares)

- Financing agreement entered into with Mackie Research Capital to undertake fully underwritten short form prospectus to raise up to C$35 million

- United Greeneries receives ACMPR amendment to sell dried marijuana to registered patients in Canada

- United Greeneries enters LOI for the lease of a property in British Columbia to accelerate and expand production

- United Greeneries announces outdoor growing strategy for premium cannabis flowers, enters into a binding purchase agreement for 398 acres of agricultural land in British Columbia

- Launch of retail sales to commence in February 2018 from United Greeneries online platform

- Satipharm obtains Free Sale Certificate from German regulators facilitating sale of CBD capsules into Australia

- Final regulatory approval granted, distribution of prescription Satipharm CBD capsules commences to approved patients in Australia

PhytoTech Therapeutics (MMJ 100%)

- Phase 1 Clinical Trial Results published in international, peer-reviewed publication Clinical Pharmacology in Drug Development

To view the full report, please visit:
http://abnnewswire.net/lnk/I139ZQ20


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

      


Contact

Andreas Gedeon
Managing Director
Phone: +1-250-713-6302
Email: agedeon@mmj.ca
www.mmjphytotech.com.au



Related Companies

MMJ PhytoTech Ltd   
Esense-Lab Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 66) (Last 30 Days: 275) (Since Published: 3651) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (25056)

Research Report

Social Media